A

AffyImmune Therapeutics

22 employees

AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.

Basic info

Industry

biotechnology research

Sectors

celltherapy
Biotechnology
cgt
gastriccancer
thyroidcancer
Biopharma
oncology
cart
Life Science

Date founded

2016

Funding rounds raised

Total raised

$20M

from 1 investors over 1 rounds

A

AffyImmune Therapeutics raised $20M on October 7, 2021

Investors: ORI Capital Limited

FAQ